生产性短QT综合征 - 审查侧重于KCNQ1 p.Val141Met变体
Minoru Horie1, Hirofumi Saiki2, Takanori Aizawa3
1Department of Cardiovascular Medicine, Shiga University of Medical Science.
概括
短QT综合征 (SQTS) 是一种罕见的遗传性心脏病. 本文重点介绍的是KCNQ1基因.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 短QT综合征 (SQTS) 是一种罕见的遗传性心律失常症.
- 在年轻人中,其特点是极短的QT间隔和突然的心脏死亡.
- 在KCNQ1基因中的功能获取变异导致SQTS类型2 (SQT2).
研究的目的:
- 总结了p.Val141Met KCNQ1变种的5名患者的发现.
- 为了将这些患者与之前报告的14例病例进行比较.
主要方法:
- 文献综述. 这是一个文献综述.
- 临床病例系列分析.
- 对KCNQ1.1的遗传变体分析.
主要成果:
- 在KCNQ1中的p.Val141Met变体是SQT2.2相对普遍的原因.
- 本综述整合了这种特定变异的19名患者的临床数据.
- 对患者发现的分析为与p.Val141Met.相关的表型提供了洞察力.
结论:
- 这种p.Val141Met变种是SQT2.的重要遗传原因.
- 了解这种变体的影响对于诊断和管理SQT2患者至关重要.
- 进一步的研究可以阐明精确的机制和临床影响.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
ATP Synthase: Structure
11.8K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
11.8K
Patch Clamp
5.3K
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
5.3K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
846
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
846
Voltage-gated Ion Channels
7.8K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
7.8K


